US Patent

US10206887 — Prion free nanoparticle compositions and methods of making thereof

Formulation · Assigned to Abraxis Bioscience LLC · Expires 2030-04-15 · 4y remaining

Vulnerability score 48/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects prion-free compositions of nanoparticles containing albumin and a substantially water-insoluble drug, such as Rapamune.

USPTO Abstract

The present invention provides prion-free compositions comprising nanoparticles comprising albumin and substantially water insoluble drugs. Also provided are methods of making prion-free compositions and methods of removing prion proteins from the nanoparticle compositions. Methods of using the compositions, as well as kits useful for carrying out the methods are also provided.

Drugs covered by this patent

Patent Metadata

Patent number
US10206887
Jurisdiction
US
Classification
Formulation
Expires
2030-04-15
Drug substance claim
No
Drug product claim
Yes
Assignee
Abraxis Bioscience LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.